Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Ambien CR safely and effectively. See full prescribing information for Ambien CR. Ambien CR® (zolpidem tartrate extended-release) tablets - CIVInitial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
Ambien CR (zolpidem tartrate extended-release tablets) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset). The clinical trials performed in support of efficacy were up to 3 weeks (using polysomnography measurement up to 2 weeks in both adult and elderly patients) and 24 weeks (using patient-reported assessment in adult patients only) in duration [see Clinical Studies (14)].
- generic_name
- zolpidem tartrate
- product_names
- zolpidem tartrate
- ndc
- 54868-5461, 54868-5426, 0024-5501, 54868-5461-0, 54868-5461-1, 0024-5521, 54868-5426-0, 54868-5426-1, 54868-5426-3, 54868-5426-4
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en